Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $1.03 Million - $1.15 Million
10,238 Added 504.58%
12,267 $1.27 Million
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $222,216 - $245,427
2,029 New
2,029 $230,000
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $185,838 - $207,062
-1,844 Reduced 26.68%
5,067 $552,000
Q1 2023

Apr 24, 2023

BUY
$96.86 - $114.01 $669,399 - $787,923
6,911 New
6,911 $699,000
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $436,961 - $528,146
-4,281 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $317,089 - $386,670
2,781 Added 185.4%
4,281 $507,000
Q4 2021

Jan 21, 2022

BUY
$115.53 - $141.46 $173,295 - $212,190
1,500 New
1,500 $211,000
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $264,475 - $311,325
-2,500 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $272,100 - $320,575
2,500 New
2,500 $300,000
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $728,572 - $811,072
-9,280 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $759,475 - $823,507
9,280 New
9,280 $773,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Machina Capital S.A.S. Portfolio

Follow Machina Capital S.A.S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Machina Capital S.A.S. with notifications on news.